We are live on
!
Find out more
AMCA
Arthur M. Cohen & Associates Portfolio holdings
AUM
$563M
1-Year Est. Return
20.97%
This Fund
S&P 500
This Quarter
Est. Return
+12.66%
1 Year Est. Return
+20.97%
3 Year Est. Return
+97.14%
5 Year Est. Return
+130.41%
10 Year Est. Return
–
AUM
$280M
AUM Growth
+$280M
(+89,043%)
Cap. Flow
-$4.45M
Cap. Flow
% of AUM
-1.59%
Top 10 Holdings %
Top 10 Hldgs %
60.02%
Holding
119
New
7
Increased
44
Reduced
29
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$1.31M |
| 2 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$934K |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$866K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$839K |
| 5 |
Blackrock
BLK
|
+$732K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$10.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.95M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$606K |
| 4 |
Kimberly-Clark
KMB
|
+$580K |
| 5 |
Philip Morris
PM
|
+$453K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.01% |
| 2 | Financials | 18.84% |
| 3 | Technology | 8.95% |
| 4 | Consumer Discretionary | 7.46% |
| 5 | Consumer Staples | 5.85% |
Similar funds
PDL
AAS
FGAM
MCM
KF
TCP
PSC
AHSW
Arthur M. Cohen & Associates's Q1 2019 Portfolio in Review
As of Q1 2019, Arthur M. Cohen & Associates held 119 positions worth $280M, up 89,043% from $314K the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Arthur M. Cohen & Associates's Q1 2019 filing shows 7 new, 44 increased, 29 reduced and 6 closed positions. Its largest new stake was Unilever: 21,441 shares worth $1.39M. The largest sale was Fortive, an estimated $10.6M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 36% a quarter earlier, followed by Financials and Technology.
- Arthur M. Cohen & Associates's largest Q1 2019 buy was Unilever: 21,441 shares worth $1.39M.
- Arthur M. Cohen & Associates added most to iShares S&P Small-Cap 600 Value ETF in Q1 2019, an estimated $934K increase.
- Arthur M. Cohen & Associates's biggest Q1 2019 reduction was Fortive, cutting an estimated $10.6M.
- Arthur M. Cohen & Associates fully exited Aevi Genomic Medicine Inc in Q1 2019, selling an estimated $38.6K.
- Arthur M. Cohen & Associates's ten largest holdings make up 60% of its $280M portfolio in Q1 2019.
- Arthur M. Cohen & Associates opened 7 new positions and closed 6 in Q1 2019.
- Arthur M. Cohen & Associates's portfolio value rose 89,043% quarter-over-quarter to $280M.
Based on Arthur M. Cohen & Associates's 13F filing for Q1 2019, filed 7 May 2019.